Protara Therapeutics, Inc. · NASDAQ:TARA
Ra Capital Management, L.P. reported a 9.90% stake in Protara Therapeutics, Inc. (Schedule 13G/A)
Event Dec 31, 2024 · Filed Feb 14, 2025
Ra Capital Management, L.P. reported a 9.90% stake in Protara Therapeutics, Inc., 3,431,713 shares, as a passive investor on Dec 31, 2024. Filed Feb 14, 2025 (Schedule 13G/A).
- Stake
- 9.90%
- Shares
- 3,431,713
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 4 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| RA Capital Management, L.P. | 9.90% | 3,431,713 |
| Peter Kolchinsky | 9.90% | 3,431,713 |
| Rajeev Shah | 9.90% | 3,431,713 |
| RA Capital Healthcare Fund, L.P. | 9.90% | 3,431,713 |
Source
Related
- Protara Therapeutics, Inc.
- Ra Capital Management, L.P.
- Protara Therapeutics, Inc. shareholders
- Schedule 13G/A · Ra Capital Management, L.P. · Aug 14, 2025
- Schedule 13G/A · Janus Henderson Group PLC · Aug 13, 2026
- Schedule 13G/A · Millennium Management LLC · Jul 7, 2026
- Form 4 · Shefferman Jesse · Jul 1, 2026
- Form 4 · Conkling William · Jun 3, 2026
- Schedule 13G/A · Janus Henderson Group PLC · May 15, 2026